Physician profile
Gregory Michael Ricketts
NPI 1326459454
$4,449.23
in general payments reported to CMS, 2019-2025
29 companies · $823 in 2025
The $823 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $2,576 · 2023: $382 · 2024: $472 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,676.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,215.21 | 2022-2025 | |
| Solventum Corporation | $302.70 | 2025 | Prevena, V.A.C. Veraflo, Activ.A.C. |
| Smith+Nephew, INC. | $269.40 | 2021-2025 | Renasys Touch, Pico 7 |
| Csl Behring | $213.98 | 2022-2025 | Kcentra |
| Davol INC. | $178.34 | 2022 | |
| Kerecis Limited | $162.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $150.00 | 2025 | Affinity |
| Lemaitre Vascular, INC. | $146.13 | 2021-2025 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Medical Device Business Services, INC. | $100.00 | 2021 | |
| Lilly USA, LLC | $87.53 | 2023-2024 | Jardiance |
| Heron Therapeutics, INC. | $58.68 | 2021-2023 | Zynrelef |
| Takeda Pharmaceuticals U.S.A., INC. | $52.14 | 2022-2023 | Gattex |
| Convatec INC. | $50.64 | 2023-2025 | |
| Urgo Medical North America, LLC | $46.15 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Tela Bio, INC. | $45.69 | 2021-2024 | Ovitex 2s |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $43.87 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Xeris Pharmaceuticals, INC. | $43.10 | 2023-2024 | Recorlev |
| Alexion Pharmaceuticals, INC. | $36.16 | 2025 | Strensiq |
| Reapplix INC. | $35.05 | 2025 | 3c Patch Kit - Box |
| Becton, Dickinson and Company | $34.44 | 2023 | |
| Medtronic, INC. | $26.83 | 2022 | |
| Lifescan, INC. | $25.98 | 2022 | |
| Acella Pharmaceuticals, LLC | $24.25 | 2024 | NP Thyroid 60 |
| Reprise Biomedical, INC. | $22.69 | 2024 | Miro3d |
| Myriad Genetic Laboratories, INC. | $18.46 | 2022 | |
| Cequr Corporation | $18.15 | 2022 | |
| Ascensia Diabetes Care US INC. | $16.29 | 2023 | |
| Vioptix INC | $15.16 | 2023 | |
| Next Science LLC | $10.13 | 2025 | Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ricketts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.